Physician profile
Eric Yt Yang
NPI 1669420113
$31,774.78
in general payments reported to CMS, 2019-2025
28 companies · $13K in 2025
The $13K reported for 2025 was more than what 96% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,946 · 2020: $579 · 2021: $720 · 2022: $1,452 · 2023: $2,468 · 2024: $11K · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $14K · Consulting Fee: $6,325 · Food and Beverage: $4,623 · Travel and Lodging: $2,105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $14,025.00 |
| Consulting Fee | $6,325.00 |
| Food and Beverage | $4,623.12 |
| Travel and Lodging | $2,105.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $27,460.24 | 2019-2025 | Grafix, Na, Oasis |
| Organogenesis INC. | $1,279.95 | 2019-2024 | Puraply, Apligraf |
| Kerecis Limited | $664.60 | 2022-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Mimedx Group, INC. | $420.45 | 2025 | |
| Kci USA, INC. | $318.20 | 2019-2023 | V.A.C. Dermatac, V.A.C. Veraflo Cleanse Choice |
| Urgo Medical North America, LLC | $299.90 | 2024-2025 | Urgoclean Ag, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Intuitive Surgical, INC. | $291.56 | 2019 | |
| Solventum Corporation | $186.41 | 2024-2025 | Prevena, V.A.C. Veraflo Cleanse Choice, Activ.A.C. |
| Tactile Systems Technology INC | $136.95 | 2019 | |
| Aroa Biosurgery Incorporated | $114.00 | 2019 | |
| Shire North American Group INC | $72.38 | 2019 | |
| Ets Wound Care LLC | $56.42 | 2025 | Mirragen Advanced Wound Matrix |
| Davol INC. | $50.02 | 2019 | |
| Bsn Medical INC | $45.63 | 2019 | |
| Angiodynamics, INC. | $41.52 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $39.88 | 2021 | |
| Baxter Healthcare | $37.69 | 2024 | Perclot |
| Takeda Pharmaceuticals U.S.A., INC. | $36.50 | 2020-2021 | |
| Polynovo North America LLC | $34.20 | 2024 | Novosorb Btm |
| Kowa Pharmaceuticals America, INC. | $28.54 | 2022 | |
| Lifenet Health | $26.69 | 2024 | Theragenesis Wound Matrix |
| Merck Sharp & Dohme LLC | $26.42 | 2019 | |
| Stryker Corporation | $21.33 | 2021 | |
| Melinta Therapeutics, LLC | $20.60 | 2019 | |
| Pfizer INC. | $18.31 | 2025 | |
| Paratek Pharmaceuticals, INC. | $17.33 | 2022 | |
| Medela LLC | $16.49 | 2022 | |
| Allergan, INC. | $12.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Yang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.